European Union plans to authorize two COVID-19 vaccines

Pfizer and Moderna vaccines could be licensed before the end of the year, the European Commission said

| 11/19/2020 | ionicons-v5-c21: 35 | AP |

BRUSSELS (AP) – Two vaccines against COVID-19 could receive a conditional marketing authorization by the second half of December, he said Thursday Ursula von der Leyen, President of the European Commission.

After holding a meeting with the leaders of the European Union, Von der Leyen pointed out that the vaccines developed by Moderna and Pfizer, which created their serum with the German pharmaceutical company BioNTech, could be approved by the end of the year by the European Medicines Agency (EMA for its acronym in English), “if everything advances now without any problem ”.

Von der Leyen added that « this is the first step to be able to be in the market ».

He also said that the EMA is in constant communication with the Food and Drug Administration of United States to synchronize the evaluation of vaccines. The European Commission has signed agreements with several pharmaceutical companies, including BioNTech and Pfizer, to purchase millions of doses of the vaccines on behalf of all EU member countries. A few days ago, Von der Leyen said the commission hopes to finalize an agreement with Moderna soon.